Haizhou Liu Selected Research

human MIRN29a microRNA

2/2020

Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haizhou Liu Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 11/2012
9	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2012
5	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2019
4	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2013
4	Carcinogenesis 01/2020 - 01/2011
3	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2018
3	Hepatocellular Carcinoma (Hepatoma) 09/2019 - 07/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
2	Influenza in Birds (Avian Flu) 01/2022 - 03/2020
2	Lung Neoplasms (Lung Cancer) 01/2022 - 02/2013
2	Virus Diseases (Viral Diseases) 12/2021 - 01/2021
2	Triple Negative Breast Neoplasms 03/2021 - 12/2019
2	Infections 01/2021 - 01/2020
2	Leukemia 01/2015 - 11/2012
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015 - 11/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2013 - 10/2012
1	COVID-19 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Microsatellite Instability 01/2021
1	Inflammation (Inflammations) 01/2021
1	Adenocarcinoma 10/2020
1	Lymphatic Metastasis 02/2020
1	Pathologic Processes 01/2020
1	Dengue (Dengue Fever) 01/2020
1	Communicable Diseases (Infectious Diseases) 08/2019
1	Burns 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Carcinoma (Carcinomatosis) 07/2015
1	Adenocarcinoma of Lung 02/2013
1	Glioma (Gliomas) 01/2011

Drug/Important Bio-Agent (IBA)

12	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2011
5	Messenger RNA (mRNA)IBA 06/2019 - 02/2013
4	Carcinoembryonic AntigenIBA 01/2021 - 01/2021
4	Long Noncoding RNAIBA 02/2020 - 06/2018
4	Peptides (Polypeptides)IBA 01/2020 - 09/2012
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2019
3	Pharmaceutical PreparationsIBA 10/2020 - 01/2015
3	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 10/2012
2	VaccinesIBA 01/2022 - 03/2020
2	InterferonsIBA 12/2021 - 01/2021
2	C-Reactive ProteinIBA 01/2021 - 01/2021
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 01/2018
2	AntigensIBA 01/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2020
2	CarbohydratesIBA 01/2021 - 01/2021
2	Phenobarbital (Luminal)FDA Link 02/2019 - 06/2018
2	Oleanolic AcidIBA 08/2013 - 10/2012
1	Hemagglutinins (Hemagglutinin)IBA 01/2022
1	LigandsIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 03/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 10/2020
1	Formaldehyde (Formol)FDA Link 02/2020
1	ParaffinIBA 02/2020
1	human MIRN29a microRNAIBA 02/2020
1	AfatinibIBA 01/2020
1	Circular RNAIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	6-methyladenineIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019
1	TCF Transcription FactorsIBA 12/2019
1	CateninsIBA 12/2019
1	RNA Splicing FactorsIBA 10/2019
1	SolutionsIBA 08/2019
1	Transcription Factors (Transcription Factor)IBA 02/2019
1	Competitive Endogenous RNAIBA 06/2018
1	dihydrouracilIBA 10/2017
1	UracilIBA 10/2017
1	Connective Tissue Growth FactorIBA 12/2015
1	S- (2- chloro- 1,1,2- trifluoroethyl)glutathioneIBA 12/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2015
1	SaponinsIBA 01/2015
1	TriterpenesIBA 08/2013
1	Matrix Metalloproteinases (MMPs)IBA 02/2013
1	Ergosterol (Lumisterol)IBA 01/2013
1	EphA2 ReceptorIBA 01/2011

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2021 - 10/2017
5	Therapeutics 02/2020 - 07/2015
2	Immunotherapy 01/2022 - 01/2020
1	Neoadjuvant Therapy 02/2020
1	Length of Stay 01/2019